TITLE

Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open-Label Trial of Linezolid versus Ampicillin-Sulbactam/ Amoxicillin-Clavulanate

AUTHOR(S)
Lipsky, Benjamin A.; Itani, Kamal; Norden, Carl
PUB. DATE
January 2004
SOURCE
Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
11791229

 

Related Articles

  • Pathogenic enterococci: new developments in the 21st century. Tendolkar, P. M.; Baghdayan, A. S.; Shankar, N. // Cellular & Molecular Life Sciences;Dec2003, Vol. 60 Issue 12, p2622 

    Enterococci, traditionally viewed as Gram-positive commensal bacteria inhabiting the alimentary canals of humans and animals, are now acknowledged to be organisms capable of causing life-threatening infections in humans, especially in the nosocomial environment. The existence of enterococci in...

  • Antimicrobial research and the development pipeline. Wiskirchen, Dora E. // Journal of the American Pharmacists Association: JAPhA;Jan/Feb2012, Vol. 52 Issue 1, p8 

    The article offers a look at new antibiotics currently in the development pipeline. Tedizolid is one of the next-generation oxazolidinones being explored for the treatment of gram-positive bacterial infections, while solithromycin is indicated for both gram-positive and atypical pathogens....

  • A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay. Desai, Mohammed; Franklin, Bryony Dean; Holmes, Alison H.; Trust, Sarah; Richards, Mike; Jacklin, Ann; Bamford, Kathleen B. // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p94 

    Background: Patients prescribed intravenous (IV) glycopeptides usually remain in hospital until completion of this treatment. Some of these patients could be discharged earlier if a switch to an oral antibiotic was made. This study was designed to identify the percentage of inpatients currently...

  • Severe Cavitary Pneumonia Caused by a Non-equi Rhodococcus Species in an Immunocompetent Patient. Ng, Stephanie; King, Christopher S; Jun Hang; Clifford, Robert; Lesho, Emil P; Kuschner, Robert A; Cox, E Darrin; Stelsel, Roscea; Mody, Rupal // Respiratory Care;Apr2013, Vol. 58 Issue 4, pE47 

    The article presents a case study of an old man, who resided on a ranch in Texas and is admitted in the hospital due to inhalational exposures. The patient was treated with intravenous meropenem, vancomycin, and rifampin, after isolating the rhodococcus specie and followed therapy for cavitary...

  • Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study. Rodriguez-Pardo, D.; Pigrau, C.; Campany, D.; Diaz-Brito, V.; Morata, L.; Diego, I.; Sorlí, L.; Iftimie, S.; Pérez-Vidal, R.; García-Pardo, G.; Larrainzar-Coghen, T.; Almirante, B. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2016, Vol. 35 Issue 8, p1269 

    Switching from intravenous to oral antibiotic therapy may improve inpatient management and reduce hospital stays and the complications of intravenous treatment. We aimed to assess the effectiveness of intravenous-to-oral antibiotic switch therapy and an early discharge algorithm in hospitalized...

  • Microbial Colonization of the Hands of Residents. Baker, Kris; Katz, Ben Z. // Clinical Pediatrics;May2006, Vol. 45 Issue 4, p341 

    To determine whether carriage of resistant Gram-positive organisms by residents increases over time, the dominant hand of pediatric residents was cultured. Among first-year residents, 53 Gram-positive organisms were isolated; 12 were resistant to oxacillin, 13 to clindamycin. Six residents had...

  • Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study. Rossolini, Gian M.; Dryden, Matthew S.; Kozlov, Roman S.; Quintana, Alvaro; Flamm, Robert K.; Läuffer, Jörg M.; Lee, Emma; Morrissey, Ian // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p151 

    Objectives To assess the in vitro activity of ceftobiprole and comparators against a recent collection of Gram-positive and Gram-negative pathogens, in order to detect potential changes in susceptibility patterns, and to evaluate the Etest assay for ceftobiprole susceptibility testing. Methods...

  • Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. Biek, Donald; Critchley, Ian A.; Riccobene, Todd A.; Thye, Dirk A. // Journal of Antimicrobial Chemotherapy (JAC);Nov2010 Supplement 4, Vol. 65 Issue suppl_4, piv9 

    Ceftaroline fosamil is a novel cephalosporin with broad-spectrum activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Streptococcus pneumoniae, and common Gram-negative organisms. The activity of ceftaroline against MRSA...

  • Cubicin Powder for Solution for Infusion.  // South African Family Practice;2014, Vol. 56 Issue 2, p86 

    The article evaluates the Cubicin® powder for solution for infusion for bacterial infection from AstraZeneca.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics